APA (7th ed.) Citation

Lorusso, D., Xiang, Y., Colombo, N., Coleman, R., Randall, L., Duska, L., . . . Pignata, S. (2020). 254TiP ENGOT-cx11/KEYNOTE-A18: A phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer. Annals of Oncology, 31, S1341. https://doi.org/10.1016/j.annonc.2020.10.248

Chicago Style (17th ed.) Citation

Lorusso, D., et al. "254TiP ENGOT-cx11/KEYNOTE-A18: A Phase III, Randomized, Double-blind Study of Pembrolizumab with Chemoradiotherapy in Patients with High-risk Locally Advanced Cervical Cancer." Annals of Oncology 31 (2020): S1341. https://doi.org/10.1016/j.annonc.2020.10.248.

MLA (9th ed.) Citation

Lorusso, D., et al. "254TiP ENGOT-cx11/KEYNOTE-A18: A Phase III, Randomized, Double-blind Study of Pembrolizumab with Chemoradiotherapy in Patients with High-risk Locally Advanced Cervical Cancer." Annals of Oncology, vol. 31, 2020, p. S1341, https://doi.org/10.1016/j.annonc.2020.10.248.